JETEMA, Co., Ltd. (KOSDAQ:216080)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,450.00
-170.00 (-3.02%)
May 20, 2026, 3:30 PM KST
Market Cap209.12B -21.4%
Revenue (ttm)76.90B +12.2%
Net Income-6.60B
EPS-184.02
Shares Out37.21M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume126,873
Average Volume463,529
Open5,620.00
Previous Close5,620.00
Day's Range5,350.00 - 5,630.00
52-Week Range5,350.00 - 11,280.00
Betan/a
RSI18.43
Earnings DateMay 22, 2026

About JETEMA,

JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers botulinum toxins, fillers, anti-aging solutions, lifting threads for medical treatment, laser surgical instruments, and skin care hyaluronic acid masks. The company is headquartered in Wonju, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 216080
Full Company Profile

Financial Performance

In 2025, JETEMA,'s revenue was 76.90 billion, an increase of 12.23% compared to the previous year's 68.52 billion. Losses were -6.60 billion, 3407.4% more than in 2024.

Financial Statements